{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:24:33Z","timestamp":1790745873489,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jid.2017.04.035","type":"journal-article","created":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T17:33:26Z","timestamp":1495128806000},"page":"1850-1859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency"],"prefix":"10.1016","volume":"137","author":[{"given":"Ryosuke","family":"Saigusa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihide","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Yoshizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Miyagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Sugaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2017.04.035_bib1","doi-asserted-by":"crossref","first-page":"R86","DOI":"10.1186\/ar4529","article-title":"Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1","volume":"16","author":"Akamata","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jid.2017.04.035_bib2","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/rheumatology\/keu479","article-title":"Increased expression of chemerin in endothelial cells due to Fli1 deficiency may contribute to the development of digital ulcers in systemic sclerosis","volume":"54","author":"Akamata","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jid.2017.04.035_bib3","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1002\/art.24681","article-title":"Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials","volume":"60","author":"Amjadi","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2017.04.035_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-1396-1_1","article-title":"Evolving mechanistic insights into galectin functions","volume":"1207","author":"Arthur","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jid.2017.04.035_bib6","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jid.2017.04.035_bib7","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/art.11129","article-title":"Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor a","volume":"48","author":"Chizzolini","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"4 Suppl. 92","key":"10.1016\/j.jid.2017.04.035_bib8","first-page":"S3","article-title":"Systemic sclerosis: from pathogenesis to targeted therapy","volume":"33","author":"Denton","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2017.04.035_bib9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/039463201002300422","article-title":"Bosentan treatment for Raynaud's phenomenon and skin fibrosis in patients with systemic sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study","volume":"23","author":"Giordano","year":"2010","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.jid.2017.04.035_bib10","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jdermsci.2009.02.013","article-title":"Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension","volume":"55","author":"Hamaguchi","year":"2009","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2017.04.035_bib11","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/eji.200939274","article-title":"TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines","volume":"39","author":"Hastings","year":"2009","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2017.04.035_bib12","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/art.39312","article-title":"Progranulin overproduction due to Fli-1 deficiency contributes to the resistance of dermal fibroblasts to tumor necrosis factor in systemic sclerosis","volume":"67","author":"Ichimura","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2017.04.035_bib13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00403-013-1431-9","article-title":"Fli1 deficiency contributes to the suppression of endothelial CXCL5 expression in systemic sclerosis","volume":"306","author":"Ichimura","year":"2014","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2017.04.035_bib14","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/ard.2004.027094","article-title":"Early T cell activation in the skin from patients with systemic sclerosis","volume":"64","author":"Kalogerou","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jid.2017.04.035_bib15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)63685-1","article-title":"Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin","volume":"163","author":"Kubo","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2017.04.035_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/rheumatology\/keq077","article-title":"Effect of bosentan on skin fibrosis in patients with systemic sclerosis: a prospective, open-label, non-comparative trial","volume":"49","author":"Kuhn","year":"2010","journal-title":"Rheumatology"},{"issue":"1 Pt. A","key":"10.1016\/j.jid.2017.04.035_bib17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.imlet.2014.09.002","article-title":"Up-regulation of Galectin-9 in\u00a0vivo results in immunosuppressive effects and prolongs survival of liver allograft in rats","volume":"162","author":"Liu","year":"2014","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jid.2017.04.035_bib18","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jaci.2014.12.1932","article-title":"Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis","volume":"135","author":"MacDonald","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2017.04.035_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00408-012-9446-0","article-title":"A\u00a0possible role of galectin-9 in the pulmonary fibrosis of patients with interstitial pneumonia","volume":"191","author":"Matsumoto","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.jid.2017.04.035_bib20","first-page":"275","article-title":"Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis","volume":"33","author":"Matsushita","year":"2006","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2017.04.035_bib21","first-page":"1751","article-title":"Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis","volume":"151","author":"Mavalia","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2017.04.035_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jdermsci.2008.01.001","article-title":"Clinical association of serum interleukin-17 levels in systemic sclerosis: is systemic sclerosis a Th17 disease?","volume":"50","author":"Murata","year":"2008","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.jid.2017.04.035_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/1346-8138.12884","article-title":"Elevated serum galectin-9 levels in patients with atopic dermatitis","volume":"42","author":"Nakajima","year":"2015","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2017.04.035_bib24","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.4049\/jimmunol.1100591","article-title":"Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts","volume":"188","author":"Nakashima","year":"2012","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2017.04.035_bib25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.clim.2009.04.012","article-title":"Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and\/or Th17-mediated skin inflammation","volume":"132","author":"Niwa","year":"2009","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jid.2017.04.035_bib26","doi-asserted-by":"crossref","first-page":"e32272","DOI":"10.1371\/journal.pone.0032272","article-title":"A\u00a0possible contribution of altered cathepsin B expression to the development of skin sclerosis and vasculopathy in systemic sclerosis","volume":"7","author":"Noda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2017.04.035_bib27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1093\/rheumatology\/kes379","article-title":"Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis","volume":"52","author":"Noda","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.jid.2017.04.035_bib28","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/exd.12602","article-title":"A\u00a0possible contribution of endothelial CCN1 downregulation due to Fli1 deficiency to the development of digital ulcers in systemic sclerosis","volume":"24","author":"Saigusa","year":"2015","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2017.04.035_bib29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/bjd.14183","article-title":"Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions","volume":"174","author":"Saigusa","year":"2016","journal-title":"Br J Dermatol"},{"issue":"2 Suppl. 71","key":"10.1016\/j.jid.2017.04.035_bib30","first-page":"S71","article-title":"CXCL11 in bronchoalveolar lavage fluid and pulmonary function decline in systemic sclerosis","volume":"30","author":"Sfriso","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jid.2017.04.035_bib31","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1128\/MCB.20.15.5643-5652.2000","article-title":"Hemorrhage, impaired hematopoiesis, and lethality in mouse embryos carrying a targeted disruption of the Fli1 transcription factor","volume":"20","author":"Spyropoulos","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jid.2017.04.035_bib32","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/bjd.14699","article-title":"A\u00a0potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis","volume":"175","author":"Takahashi","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2017.04.035_bib33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/bjd.13779","article-title":"A\u00a0possible contribution of lipocalin-2 to the development of dermal fibrosis, pulmonary vascular involvement and renal dysfunction in systemic sclerosis","volume":"173","author":"Takahashi","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2017.04.035_bib34","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2017.04.035_bib35","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/art.38948","article-title":"Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice","volume":"67","author":"Taniguchi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jid.2017.04.035_bib36","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jid.2017.04.035_bib37","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/bjd.14718","article-title":"Psoriasin (S100A7) promotes stress-induced angiogenesis","volume":"175","author":"Vegfors","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2017.04.035_bib38","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"33 Suppl. 1","key":"10.1016\/j.jid.2017.04.035_bib39","doi-asserted-by":"crossref","first-page":"E102","DOI":"10.1002\/med.20249","article-title":"Therapeutic potential of galectin-9 in human disease","author":"Wiersma","year":"2013","journal-title":"Med Res Rev"},{"key":"10.1016\/j.jid.2017.04.035_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/exd.12920","article-title":"A\u00a0potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis","volume":"25","author":"Yamashita","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2017.04.035_bib41","doi-asserted-by":"crossref","first-page":"F822","DOI":"10.1152\/ajprenal.00294.2013","article-title":"Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice","volume":"306","author":"Zhang","year":"2014","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17315403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X17315403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T08:55:11Z","timestamp":1542963311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X17315403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0022202X17315403"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2017.04.035","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2017.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}